Prices are updated after-hours


Sort by: gain open | gain high | gain close | publishing date

symbols : AMRX    save search

BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
JNJ | News | $167.27 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
GSK | News | $45.14 | twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.0% C: 0.0%
LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -1.71% H: 0.0% C: 0.0%
MRTX | News | $118.34 | twitter stocktwits trandingview |
Health Technology
| | O: -2.14% H: 0.0% C: 0.0%
GILD | $67.81 | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.0% C: 0.0%
GLAXF | News | $22.8 | twitter stocktwits trandingview |
Health Technology
| | O: -1.67% H: 3.62% C: 3.62%
PPG | $159.7 | twitter stocktwits trandingview |
Process Industries
| | O: -2.07% H: 0.0% C: 0.0%
AMGN | $233.73 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
PHAT | $15.0 | twitter stocktwits trandingview |
Health Technology
| | O: -3.08% H: 0.0% C: 0.0%

space spac
Amneal Acquires Saol Therapeutics’ Baclofen Franchise
Published: 2022-01-05 (Crawled : 12:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 0.2% H: 4.29% C: -2.86%

era therapeutics
Amneal to Virtually Participate at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2021-12-21 (Crawled : 15:30) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 2.41% H: 2.57% C: 0.0%

health thc conference j.p. morgan healthcare conference
TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA® (Estradiol and Progesterone) — Allowing for a May 25, 2032 Generic Entry Date
Published: 2021-12-08 (Crawled : 14:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.12% C: -0.47%
TXMD | $0.34 | twitter stocktwits trandingview |
Health Technology
| | O: 8.64% H: 7.27% C: 5.14%

bijuva era patent therapeutics
Amneal Receives Approval for Difluprednate Ophthalmic Emulsion
Published: 2021-11-19 (Crawled : 14:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -1.31% H: 4.08% C: 1.99%

approval
Amneal Reports Third Quarter 2021 Financial Results
Published: 2021-11-03 (Crawled : 11:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -3.02% H: 3.3% C: -2.39%

financial results results
Amneal Releases Inaugural Corporate Responsibility Report Highlighting Our Impact as a Socially Responsible Company
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 0.0% C: 0.0%


Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA
Published: 2021-10-27 (Crawled : 14:15) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -0.72% H: 0.0% C: -2.91%

fda approval
Ampio Pharmaceuticals Strengthens Management Team and Board of Directors
Published: 2021-10-13 (Crawled : 13:15) - prnewswire.com
TEVA | $8.64 | twitter stocktwits trandingview |
Health Technology
| | O: 0.41% H: 1.01% C: -0.61%
CBIO | $0.6768 | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 1.22% C: 0.0%
LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 1.64% C: 1.01%
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 1.03% C: -2.57%
FWP | $5.58 | twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 9.42% C: 1.73%
DRNA | $37.81 | twitter stocktwits trandingview |
Health Technology
| | O: 0.68% H: 3.39% C: 1.65%
AMPE | $0.495 | twitter stocktwits trandingview |
Health Technology
| | O: -1.18% H: 1.2% C: 0.0%


Amneal to Report Third Quarter 2021 Results on November 3, 2021
Published: 2021-10-06 (Crawled : 13:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -1.66% H: 2.06% C: 1.12%

results
Amneal Announces Positive Topline Results from Pivotal Phase 3 RISE-PD Clinical Trial of IPX-203 in Patients with Parkinson’s Disease Who Experience Motor Fluctuations
Published: 2021-08-25 (Crawled : 21:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 1.45% C: 0.36%

disease positive results topline parkinson phase 3 trial
Amneal Announces Virtual Event to Discuss Initial Data from Pivotal Phase 3 Study of IPX-203 in Patients with Parkinson’s Disease Who Experience Motor Fluctuations
Published: 2021-08-23 (Crawled : 13:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 1.44% H: 9.13% C: 7.3%

disease parkinson phase 3
Amneal Reports Second Quarter 2021 Financial Results
Published: 2021-08-09 (Crawled : 11:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 2.58% H: 1.55% C: -0.39%

financial results results
Amneal Receives Approval for Generic TobraDex®
Published: 2021-07-19 (Crawled : 21:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -2.09% H: 2.37% C: 2.37%

approval
Amneal to Report Second Quarter 2021 Results on August 9, 2021
Published: 2021-07-15 (Crawled : 14:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 1.34% C: -2.68%

results
Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab
Published: 2021-06-17 (Crawled : 12:15) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 0.52% H: 0.0% C: -4.14%

fda license application
Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster Headaches
Published: 2021-06-07 (Crawled : 18:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 0.92% H: 4.72% C: 3.27%

migraine
Alkermes Announces the Appointment of Emily Peterson Alva to its Board of Directors
Published: 2021-05-20 (Crawled : 11:00) - investor.alkermes.com
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.17% C: -1.21%
ALKS | $24.32 | twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 0.78% C: 0.46%


Amneal Reports First Quarter 2021 Financial Results
Published: 2021-05-07 (Crawled : 14:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 1.21% H: 0.34% C: -11.11%

financial results results
Amneal to Report First Quarter 2021 Results on May 7, 2021
Published: 2021-04-15 (Crawled : 13:00) - biospace.com/
AMRX | $4.4 | twitter stocktwits trandingview |
Health Technology
| | O: 1.55% H: 1.02% C: -0.17%

results
Your saved searches


Save your searches and get alerts when important news are released.

Mentioned Today
COTY | News | $8.64 | twitter stocktwits trandingview |
Consumer Non-Durables

DXR | News | $11.16 | twitter stocktwits trandingview |
Health Technology

FCFS | News | $73.31 | twitter stocktwits trandingview |
Finance

INCY | News | $74.76 | twitter stocktwits trandingview |
Health Technology

KRP | News | $14.73 | twitter stocktwits trandingview |
Miscellaneous

LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology

OVLY | News | $17.6 | twitter stocktwits trandingview |
Finance